Assignee
ILDONG PHARMACEUTICAL CO LTD
KR·11 granted patents·19 pending applications·6 citations·filing 2008–2024
Top patents by PatentIndex Score
30 records- 0189US11643403B2GLP-1 receptor agonist and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2020·Granted May 9, 2023·3 cites·14 claims
- 0286US11806350B2Prevention and/or treatment of CNS disordersILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Nov 7, 2023·1 cites·16 claims
- 0385US11731961B2Phenyl propionic acid derivatives and uses thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Aug 22, 2023·1 cites·16 claims
- 0482US11970493B2Autotaxin inhibitor compoundsILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Apr 30, 2024·1 cites·51 claims
- 0572US2024246961A1Autotaxin inhibitor compoundsILDONG PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0670US2024041888A1Prevention and/or treatment of cns disordersILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0768US11932618B2GLP-1 receptor agonist and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Granted Mar 19, 2024·0 cites·15 claims
- 0866US2023373954A1Novel acid secretion inhibitor and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0965US11912674B2Isoxazole derivatives as nuclear receptor agonists and uses thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Feb 27, 2024·0 cites·13 claims
- 1065US2024199623A1SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS CFTR MODULATORSILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1163US11767311B2Acid secretion inhibitor and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 26, 2023·0 cites·9 claims
- 1260US2023320991A1Non-stop production process for improving freeze-drying survival, heat tolerance, shelf stability and digestive stability of probiotics using spontaneous matrix-encapsulation techniqueILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1358US11826413B2Pharmaceutical composition comprising attenuated Streptococcus pneumoniae strains and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Nov 28, 2023·0 cites·5 claims
- 1458US2025214968A1Novel Salt of GLP-1 Receptor Agonist Compound, Preparation Method Thereof and Pharmaceutical Composition Comprising ThereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1558US2025042872A1Novel salt of 1-sulfonyl pyrrole derivative, method for preparing same, and pharmaceutical composition including sameILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1658US2025084026A1Novel salt of 1-sulfonyl pyrrole derivative, preparation method thereof and pharmaceutical composition comprising thereofILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1757US11827640B2Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulatorsILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Nov 28, 2023·0 cites·24 claims
- 1857US2025388582A1Novel bicyclic heteroaryl compound and use thereofILDONG PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1956US2022380376A1Nitrogen Oxide-Donating PDE-5 and/or PDE-6 Inhibitor CompoundsILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2055US2023136331A1Immunocytokine containing il-21r muteinILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2155US2024366579A1Pharmaceutical composition comprising gpr40 agonist and sglt-2 inhibitorILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2254US2022112185A1Novel phenyl propionic acid derivatives and uses thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2353US2022409598A1Method of controlling blood sugar level and treatment of diabetes and related conditionsILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2453US2022153746A1Nitrogen oxide-donating pde-5 and/or pde-6 inhibitor compounds, and uses thereofILDONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2552US2022204449A1Biased agonists of opioid receptorsILDONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2651US2023080054A1Inhibitors of anoctamin 6 protein and uses thereofILDONG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2749US2023022803A1Novel crystalline form of gpr40 agonistILDONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2848US11787812B2Substituted pyrazolo[4,3-d]pyrimidines and imidazo[5,1 -f][1,2,4]triazines as androgen receptor and phosphodiesterase dual inhibitorsILDONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Oct 17, 2023·0 cites·44 claims
- 2947US2010168421A1A new peptide deformylase inhibitor compound and manufacturing process thereofILDONG PHARMACEUTICAL CO LTD·Filed 2008·Application pending·0 cites
- 3038US10894086B2Functional hydrated hyaluronic acid and method for producing coated lactic acid bacteria having excellent intestinal mucoadhesive ability and selective antagonistic action using sameILDONG PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 19, 2021·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when ILDONG PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →